Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicle transport through interaction with t-SNAREs 1B (VTI1B) is a membrane-associated SNARE protein that mediates vesicle transport and fusion by interacting with t-SNAREs on target membranes[3][1][4]. It is primarily localized to the Golgi apparatus, endosomes, lysosomes, and plasma membrane, where it facilitates fusion of endocytic, lysosomal, and autophagic vesicles[2][3][4]. VTI1B enables specificity in vesicular trafficking and is critical in processes such as autophagy (including autophagosome-lysosome fusion for intracellular pathogen clearance), cytokine secretion, and immune cell function—specifically antigen processing and presentation in B lymphocytes and lytic granule tethering in cytotoxic T cells[2][4][1]. VTI1B is implicated in certain immunological disorders (e.g., hemophagocytic lymphohistiocytosis), but no direct pharmacological modulators are noted[3]. Functional redundancy with other SNARE family members, such as VTI1A, exists in some cell types[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle transport through interaction with t-SNAREs 1B (VTI1B).